Literature DB >> 22237799

Mechanisms of p53 activation and physiological relevance in the developing kidney.

Karam Aboudehen1, Sylvia Hilliard, Zubaida Saifudeen, Samir S El-Dahr.   

Abstract

The tumor suppressor protein p53 is a short-lived transcription factor due to Mdm2-mediated proteosomal degradation. In response to genotoxic stress, p53 is stabilized via posttranslational modifications which prevent Mdm2 binding. p53 activation results in cell cycle arrest and apoptosis. We previously reported that tight regulation of p53 activity is an absolute requirement for normal nephron differentiation (Hilliard S, Aboudehen K, Yao X, El-Dahr SS Dev Biol 353: 354-366, 2011). However, the mechanisms of p53 activation in the developing kidney are unknown. We show here that metanephric p53 is phosphorylated and acetylated on key serine and lysine residues, respectively, in a temporal profile which correlates with the maturational changes in total p53 levels and DNA-binding activity. Site-directed mutagenesis revealed a differential role for these posttranslational modifications in mediating p53 stability and transcriptional regulation of renal function genes (RFGs). Section immunofluorescence also revealed that p53 modifications confer the protein with specific spatiotemporal expression patterns. For example, phos-p53(S392) is enriched in maturing proximal tubular epithelial cells, whereas acetyl-p53(K373/K382/K386) are expressed in nephron progenitors. Functionally, p53 occupancy of RFG promoters is enhanced at the onset of tubular differentiation, and p53 loss or gain of function indicates that p53 is necessary but not sufficient for RFG expression. We conclude that posttranslational modifications are important determinants of p53 stability and physiological functions in the developing kidney. We speculate that the stress/hypoxia of the embryonic microenvironment may provide the stimulus for p53 activation in the developing kidney.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237799      PMCID: PMC3330719          DOI: 10.1152/ajprenal.00642.2011

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  50 in total

1.  Tight regulation of p53 activity by Mdm2 is required for ureteric bud growth and branching.

Authors:  Sylvia Hilliard; Karam Aboudehen; Xiao Yao; Samir S El-Dahr
Journal:  Dev Biol       Date:  2011-03-21       Impact factor: 3.582

Review 2.  The p53 pathway: positive and negative feedback loops.

Authors:  Sandra L Harris; Arnold J Levine
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

3.  A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene.

Authors:  Deepti S Wilkinson; Stacey K Ogden; Sabrina A Stratton; Julie L Piechan; Thi T Nguyen; George A Smulian; Michelle Craig Barton
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

4.  Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress.

Authors:  J Frenkel; D Sherman; A Fein; D Schwartz; N Almog; A Kapon; N Goldfinger; V Rotter
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

5.  The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53.

Authors:  D Keller; X Zeng; X Li; M Kapoor; M S Iordanov; Y Taya; G Lozano; B Magun; H Lu
Journal:  Biochem Biophys Res Commun       Date:  1999-08-02       Impact factor: 3.575

Review 6.  The role of apoptosis in cancer development and treatment response.

Authors:  J Martin Brown; Laura D Attardi
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

7.  Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation.

Authors:  Zubaida Saifudeen; Susana Dipp; Hao Fan; Samir S El-Dahr
Journal:  Am J Physiol Renal Physiol       Date:  2005-01-04

8.  Regulation of p53 activity through lysine methylation.

Authors:  Sergei Chuikov; Julia K Kurash; Jonathan R Wilson; Bing Xiao; Neil Justin; Gleb S Ivanov; Kristine McKinney; Paul Tempst; Carol Prives; Steven J Gamblin; Nickolai A Barlev; Danny Reinberg
Journal:  Nature       Date:  2004-11-03       Impact factor: 49.962

9.  Regulation of p53 function and stability by phosphorylation.

Authors:  M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

10.  High-frequency developmental abnormalities in p53-deficient mice.

Authors:  J F Armstrong; M H Kaufman; D J Harrison; A R Clarke
Journal:  Curr Biol       Date:  1995-08-01       Impact factor: 10.834

View more
  9 in total

1.  In situ histone landscape of nephrogenesis.

Authors:  Nathan McLaughlin; Fenglin Wang; Zubaida Saifudeen; Samir S El-Dahr
Journal:  Epigenetics       Date:  2013-10-29       Impact factor: 4.528

Review 2.  Renal progenitors and childhood: from development to disorders.

Authors:  Francesca Becherucci; Elena Lazzeri; Laura Lasagni; Paola Romagnani
Journal:  Pediatr Nephrol       Date:  2014-01-04       Impact factor: 3.714

3.  Podocyte p53 Limits the Severity of Experimental Alport Syndrome.

Authors:  Ryosuke Fukuda; Mary Ann Suico; Yukari Kai; Kohei Omachi; Keishi Motomura; Tomoaki Koga; Yoshihiro Komohara; Kosuke Koyama; Tsubasa Yokota; Manabu Taura; Tsuyoshi Shuto; Hirofumi Kai
Journal:  J Am Soc Nephrol       Date:  2015-05-12       Impact factor: 10.121

Review 4.  The MDM2-p53 pathway: multiple roles in kidney development.

Authors:  Samir El-Dahr; Sylvia Hilliard; Karam Aboudehen; Zubaida Saifudeen
Journal:  Pediatr Nephrol       Date:  2014-04       Impact factor: 3.714

5.  Silencing CCNG1 protects MPC-5 cells from high glucose-induced proliferation-inhibition and apoptosis-promotion via MDM2/p53 signaling pathway.

Authors:  Ye Chen; Rui Yan; Bo Li; Jun Liu; Xiaoxia Liu; Wenyu Song; Chunling Zhu
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

6.  Editor's Highlight: Hydroxyurea Exposure Activates the P53 Signaling Pathway in Murine Organogenesis-Stage Embryos.

Authors:  Nazem El Husseini; Ava E Schlisser; Barbara F Hales
Journal:  Toxicol Sci       Date:  2016-05-13       Impact factor: 4.849

Review 7.  Regulation of kidney development by the Mdm2/Mdm4-p53 axis.

Authors:  Samir El-Dahr; Sylvia Hilliard; Zubaida Saifudeen
Journal:  J Mol Cell Biol       Date:  2017-02-01       Impact factor: 6.216

8.  Hydroxyurea affects in vitro porcine oocyte maturation through increased apoptosis and oxidative stress.

Authors:  Wei Gao; Yongxun Jin; Jindong Hao; Siyi Huang; Dongxu Wang; Fushi Quan; Mingjun Zhang; Jiabao Zhang; Wenzhi Ren; Xianfeng Yu
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

9.  A p53-Pax2 pathway in kidney development: implications for nephrogenesis.

Authors:  Zubaida Saifudeen; Jiao Liu; Susana Dipp; Xiao Yao; Yuwen Li; Nathaniel McLaughlin; Karam Aboudehen; Samir S El-Dahr
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.